Embracing Neurodiversity in Psychedelic Science: A Mixed-Methods Inquiry into the MDMA Experiences of Autistic Adults Read More > March 25, 2019
A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy. Read More > March 20, 2019
Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case Example. Read More > March 19, 2019
Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers Read More > February 28, 2019
Emerging from the dark side: new therapeutic applications of scheduled psychoactive substances Read More > February 14, 2019
Perceived Benefits of MDMA-Assisted Psychotherapy beyond Symptom Reduction: Qualitative Follow-Up Study of a Clinical Trial for Individuals with Treatment-Resistant PTSD. Read More > January 7, 2019
Role of serotonin transporter and receptor gene variations in the acute effects of MDMA in healthy subjects Read More > December 27, 2018
Methylenedioxymethamphetamine (MDMA) in Psychiatry: Pros, Cons, and Suggestions. Read More > December 12, 2018
3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats Read More > December 4, 2018
